331 related articles for article (PubMed ID: 27277934)
1. Statin use and the risk of developing diabetes: a network meta-analysis.
Thakker D; Nair S; Pagada A; Jamdade V; Malik A
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1131-1149. PubMed ID: 27277934
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
3. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Naci H; Brugts J; Ades T
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
[TBL] [Abstract][Full Text] [Related]
4. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
[TBL] [Abstract][Full Text] [Related]
6. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.
Zhang X; Xing L; Jia X; Pang X; Xiang Q; Zhao X; Ma L; Liu Z; Hu K; Wang Z; Cui Y
Cardiovasc Ther; 2020; 2020():3987065. PubMed ID: 32411300
[TBL] [Abstract][Full Text] [Related]
7. Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis.
Hu YB; Hu ED; Fu RQ
Gastroenterol Res Pract; 2018; 2018():8620682. PubMed ID: 30254671
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
[TBL] [Abstract][Full Text] [Related]
9. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
10. Effect of different types and dosages of statins on plasma lipoprotein(a) levels: A network meta-analysis.
Wang X; Li J; Ju J; Fan Y; Xu H
Pharmacol Res; 2021 Jan; 163():105275. PubMed ID: 33166736
[TBL] [Abstract][Full Text] [Related]
11. Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials.
Hou Q; Chen Y; Zhang Y; Pang C
Cardiovasc Drugs Ther; 2024 Jun; 38(3):459-469. PubMed ID: 36447018
[TBL] [Abstract][Full Text] [Related]
12. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
Preiss D; Seshasai SR; Welsh P; Murphy SA; Ho JE; Waters DD; DeMicco DA; Barter P; Cannon CP; Sabatine MS; Braunwald E; Kastelein JJ; de Lemos JA; Blazing MA; Pedersen TR; Tikkanen MJ; Sattar N; Ray KK
JAMA; 2011 Jun; 305(24):2556-64. PubMed ID: 21693744
[TBL] [Abstract][Full Text] [Related]
13. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.
ChruĊciel P; Sahebkar A; Rembek-Wieliczko M; Serban MC; Ursoniu S; Mikhailidis DP; Jones SR; Mosteoru S; Blaha MJ; Martin SS; Rysz J; Toth PP; Lip GY; Pencina MJ; Ray KK; Banach M;
Atherosclerosis; 2016 Oct; 253():194-208. PubMed ID: 27498397
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
15. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
Lu Y; Cheng Z; Zhao Y; Chang X; Chan C; Bai Y; Cheng N
Atherosclerosis; 2016 Nov; 254():215-227. PubMed ID: 27764723
[TBL] [Abstract][Full Text] [Related]
17. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Sattar N; Preiss D; Murray HM; Welsh P; Buckley BM; de Craen AJ; Seshasai SR; McMurray JJ; Freeman DJ; Jukema JW; Macfarlane PW; Packard CJ; Stott DJ; Westendorp RG; Shepherd J; Davis BR; Pressel SL; Marchioli R; Marfisi RM; Maggioni AP; Tavazzi L; Tognoni G; Kjekshus J; Pedersen TR; Cook TJ; Gotto AM; Clearfield MB; Downs JR; Nakamura H; Ohashi Y; Mizuno K; Ray KK; Ford I
Lancet; 2010 Feb; 375(9716):735-42. PubMed ID: 20167359
[TBL] [Abstract][Full Text] [Related]
18. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.
Coleman CI; Reinhart K; Kluger J; White CM
Curr Med Res Opin; 2008 May; 24(5):1359-62. PubMed ID: 18384710
[TBL] [Abstract][Full Text] [Related]
19. Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.
Rahal AJ; ElMallah AI; Poushuju RJ; Itani R
Saudi Med J; 2016 Oct; 37(10):1051-60. PubMed ID: 27652354
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
